Novartis buys gene therapy company Arctos Medical

Reuters2021-09-21

ZURICH, Sept 21 (Reuters) - Novartis has bought gene therapy specialist Arctos Medical to boost its efforts finding treatments for patients with severe vision loss, the Swiss company said on Tuesday.

The acquisition, for an undisclosed amount, underscores Novartis' commitment to using optogenetics-based therapies to restore vision to patients with advanced blindness, it said.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
1